Oct 24, 2019

Notice of Revisions to Dividend Forecast for Fiscal Year Ending December 31, 2019

Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (1st Section of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
President & CEO: Tatsuro Kosaka
Inquiries to: Masahiko Uchida,
General Manager, Corporate Communications Dept.

Chugai Pharmaceutical Co., Ltd. announced that the Company resolved at the meeting of its Board of Directors held on October 24, 2019 to revise the dividend forecast per share as described below.

1. Reasons for the revision
Reflecting the significant changes in the profit structures, year-end dividend forecast has been revised to undecided. The year-end dividends will be decided after the fiscal year end based on basic profit distribution principles*.

*Regarding income distribution, taking into account the strategic funding needs and earning prospects, Chugai aims for a consolidated dividend payout ratio of 50% on average in comparison with Core EPS to provide a stable allocation of profit to all shareholders.

2. Contents of the revision

Annual dividends per share (JPY)
End of second quarterEnd of FYTotal
Previous forecast (A) JPY 48.00 JPY 96.00
Revised forecast (B) Undecided Undecided
Results for FY ending Dec. 2019 JPY 48.00
Results for FY ending Dec. 2018 JPY 31.00 JPY 55.00 JPY 86.00


  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Tomoko Shimizu
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Toshiya Sasai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp
  • Like
  • Post
  • LINE it!
  • E-mail
Back to top